In response to a serum potassium of 6.5 mEq/L and a provider's instruction to adjust the potassium chloride, what is the nurse's most important action?

Prepare for the HESI Chronic Kidney Disease Case Study Exam with multiple-choice questions and detailed explanations. Boost your confidence for success!

Multiple Choice

In response to a serum potassium of 6.5 mEq/L and a provider's instruction to adjust the potassium chloride, what is the nurse's most important action?

Explanation:
When potassium is this high, the priority is to stop giving more potassium and get the provider involved right away. A serum potassium of 6.5 mEq/L is hyperkalemia, and in CKD patients the risk of dangerous heart rhythm problems is real. Continuing or adjusting the potassium chloride without a provider’s orders could worsen the situation, so the safest immediate action is to hold the dose and report the elevated level. After holding the dose, inform the healthcare provider so they can decide the next steps—whether to discontinue potassium supplementation, order tests (like an ECG and repeat potassium level), or initiate treatments to lower potassium. While waiting, monitor the patient for signs of hyperkalemia and review other potential potassium sources (diet, PRN meds, salt substitutes) to prevent further increases. Why the other options aren’t appropriate here: continuing the current plan would risk further elevation; reducing the dose without an order isn’t guaranteed to be safe or effective; switching to a slower-acting formulation doesn’t address the acute risk of a high potassium level and doesn’t replace the need for provider guidance.

When potassium is this high, the priority is to stop giving more potassium and get the provider involved right away. A serum potassium of 6.5 mEq/L is hyperkalemia, and in CKD patients the risk of dangerous heart rhythm problems is real. Continuing or adjusting the potassium chloride without a provider’s orders could worsen the situation, so the safest immediate action is to hold the dose and report the elevated level.

After holding the dose, inform the healthcare provider so they can decide the next steps—whether to discontinue potassium supplementation, order tests (like an ECG and repeat potassium level), or initiate treatments to lower potassium. While waiting, monitor the patient for signs of hyperkalemia and review other potential potassium sources (diet, PRN meds, salt substitutes) to prevent further increases.

Why the other options aren’t appropriate here: continuing the current plan would risk further elevation; reducing the dose without an order isn’t guaranteed to be safe or effective; switching to a slower-acting formulation doesn’t address the acute risk of a high potassium level and doesn’t replace the need for provider guidance.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy